These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3548117)

  • 1. [Immunologic-cytologic monitoring of heart transplant patients].
    Hammer C
    Z Kardiol; 1986; 75 Suppl 5():121-3. PubMed ID: 3548117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic-cytologic monitoring following heart transplantation].
    Lersch C; Hammer C; Klanke D; Reichenspurner H; Kemkes BM
    Fortschr Med; 1988 Sep; 106(27):541-3. PubMed ID: 3053374
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoimmunologic monitoring for the diagnosis of acute rejection after heart transplantation.
    Wijngaard PL; van der Meulen A; Schuurman HJ; Gmelig Meyling FH; Heyn A; Borleffs JC; Jambroes G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2521-2. PubMed ID: 2650320
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial interleukin-6 blood levels early after cardiac transplantation.
    Weyand M; Krehmeier M; Fahrenkamp A; Middendorf C; Redmann M; Schwartz C; Konertz W; Scheld HH
    Transplant Proc; 1992 Dec; 24(6):2546. PubMed ID: 1334584
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyto-immunologic monitoring following heart transplantation.
    Wijngaard PL; Heyn A; van der Meulen A; de Vries H
    Bibl Cardiol; 1988; (43):137-41. PubMed ID: 3067713
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence of interstitial inflammation after episodes of cardiac rejection associated with systemic infection.
    Durham JR; Nakhleh RE; Levine A; Levine TB
    J Heart Lung Transplant; 1995; 14(4):774-80. PubMed ID: 7578188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
    Semik M; Konertz W; Westphal E; Heusermann U; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):133-6. PubMed ID: 3067712
    [No Abstract]   [Full Text] [Related]  

  • 10. Reproducibility and reliability of cytoimmunological monitoring (CIM) of heart transplanted patients (HTP).
    Klanke D; Hammer C; Schübel C; Caca C; Dirschedl P; Gokel M; Kemkes BM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2512-3. PubMed ID: 2650316
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive patient control after heart transplantation. A 6-year experience at the Munich University Hospital.
    Kemkes BM; Angermann C; Haberl R; Reichenspurner H; Klanke D; Anthuber M; Gokel M
    Bibl Cardiol; 1988; (43):119-27. PubMed ID: 3067710
    [No Abstract]   [Full Text] [Related]  

  • 12. [The patient following heart transplantation].
    Tscheliessnigg KH
    Wien Med Wochenschr; 1990 Jun; 140(10-11):284-6. PubMed ID: 2114706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical moments in the formal pathogenesis of the rejection reaction in the orthotopic heart transplant with prognostic significance].
    Kemnitz J; Cohnert T; Haverich A; Choritz H; Borchert A
    Pathologe; 1988 May; 9(3):164-71. PubMed ID: 3043416
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoimmunologic monitoring (CIM) for differentiation between cardiac rejection and viral, bacterial, or fungal infection: its specificity and sensitivity.
    Hammer C; Klanke D; Lersch C; Dirschedl P; Kemkes BM; Gokel M; Reichenspurner H; Reichart B
    Transplant Proc; 1989 Aug; 21(4):3631-3. PubMed ID: 2669269
    [No Abstract]   [Full Text] [Related]  

  • 16. Session VI: Rejection/infection: the limits of heart transplantation success.
    Behrendt DM; Billingham ME; Boucek MM; Marxmiller JM; Rose EA; Marcelletti C
    J Heart Lung Transplant; 1991; 10(5 Pt 2):841-7. PubMed ID: 1742296
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac transplantation in children.
    Taylor SR; Yunis EJ; Fricker FJ
    Perspect Pediatr Pathol; 1991; 14():60-93. PubMed ID: 2038549
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection of the transplanted heart.
    Murdock DK; Collins EG; Lawless CE; Molnar Z; Scanlon PJ; Pifarre R
    Heart Lung; 1987 May; 16(3):237-45. PubMed ID: 3553082
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 20. [The follow-up of the heart transplant patient].
    Perini G; Bonadiman C
    G Ital Cardiol; 1998 Dec; 28(12):1378-84. PubMed ID: 9887391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.